New dry eye therapy now TGA-approved
Australian drug regulators have approved a new aqueous, immunosuppressant for the treatment of moderate-to-severe dry eye. Cequa (ciclosporin 900 microgram/mL) ...
Tag: Therapeutic Drug Administration
Novartis secures approval for AMD drug in Australia
Australia’s ophthalmic community has welcomed the approval of Novartis’ latest therapy for neovascular age-related macular degeneration (nAMD). Advocates hope the ...